An interventional study of Programmed Intermittent Bolus and Continuous Infusion in Thoracic Diseases, sponsored by Mayo Clinic. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-04-01.
Sponsored by Mayo Clinic · Not applicable, Interventional, and Other
The researchers are trying to determine pain medication consumption in the first 24 hours after surgery in patients given the standard continuous infusion of local anesthetic versus patients given the same total dose via programmed intermittent dosing. Both groups will receive the option of patient controlled pain medication as well as the same dose of pre-programmed pain medication. The only difference is the rate of administration: continuous vs. hourly intervals.
72 studies on the registry are indexed under Thoracic Diseases; 13 are open to participants now.
This study's enrollment of 50 is below the median of 65 across 52 interventional studies indexed under Thoracic Diseases.
Browse Thoracic Diseases studies →Mayo Clinic is the lead sponsor of 3,269 studies on the registry; 672 are open to participants now.
Of its 452 completed or terminated interventional studies of FDA-regulated products, 321 (71%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
6 mL 0.2% ropivacaine hourly, starting on arrival to PACU, given via an hourly programmed bolus
Other: Programmed Intermittent Bolus
6 mL 0.2% ropivacaine hourly, starting on arrival to PACU, given via continuous infusion
Other: Continuous Infusion
6 mL 0.2% ropivacaine hourly, starting on arrival to PACU, given via an hourly programmed bolus
6 mL 0.2% ropivacaine hourly, starting on arrival to PACU, given via continuous infusion
Opioid consumption 24 hours postoperatively
morphine equivalents of opioids in mg will be obtained from medical record
Time frame: first 24 hours postoperatively
Opioid consumption 48 hours postoperatively
morphine equivalents of opioids in mg will be obtained from medical record
Time frame: first 48 hours postoperatively
Ran from Feb 2018 to primary completion in Jan 2020, 23 months.
Of 27 interventional studies with no phase under Thoracic Diseases, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 42. This study's 23 months is close to that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.